Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.31 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.31 |
| ▸ | ARG1 | P05089 | 1/20 | 0.30 |
| ▸ | ARG2 | P78540 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26108087 | 0.95 | CYP4F2 (0.30) | CYP4F2CYP4A11 | |
| SCHEMBL7874343 | 0.95 | CYP4F2 (0.30) | CYP4F2CYP4A11 | |
| SCHEMBL7488055 | 0.91 | CYP4F2 (0.30) | CYP4F2CYP4A11 | |
| SCHEMBL8143545 | 0.81 | NPSR1 (0.37) | CYP4F2CYP4A11 | |
| SCHEMBL9212453 | 0.80 | — | — | |
| SCHEMBL7333852 | 0.80 | — | — | |
| SCHEMBL27383131 | 0.79 | DGAT1 (0.35) | — | |
| SCHEMBL27573161 | 0.78 | — | — | |
| SCHEMBL4590196 | 0.78 | — | — | |
| SCHEMBL11306523 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240065261-A1 | PENETRATING CRYOPROTECTION AGENTS AND METHODS OF MAKING AND USING SAME | UNIV NEW YORK STATE RES FOUND (US) | 2024-02-29 | — | — | US | disclosed |
| EP-4262778-A1 | PENETRATING CRYOPROTECTION AGENTS AND METHODS OF MAKING AND USING SAME | The Research Foundation for The State University of New York (US) | 2023-10-25 | — | — | EP | disclosed |
| CN-116916910-A | Permeable cryoprotectants and methods of making and using the same | 纽约州立大学研究基金会 | 2023-10-20 | — | — | CN | disclosed |
| US-20220348558-A1 | INHIBITORS OF ENCEPHALITIC ALPHAVIRUSES | UT RESEARCH FOUNDATION | 2022-11-03 | — | — | US | disclosed |
| WO-2022140458-A1 | PENETRATING CRYOPROTECTION AGENTS AND METHODS OF MAKING AND USING SAME | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2022-06-30 | — | — | WO | disclosed |
| US-5225528-A | Controlling premature labor | MERCK & CO., INC. (US) | 1993-07-06 | — | — | US | disclosed |
| US-RE34165-E | Pentapeptide immunoregulators | ORTHO PHARMACEUTICAL CORPORATION (US) | 1993-01-19 | — | — | US | disclosed |
| EP-0444898-A1 | Cyclic hexapeptide oxytocin antagonists | MERCK & CO. INC. (US) | 1991-09-04 | — | — | EP | disclosed |
| EP-0146266-B1 | ENZYME-RESISTANT IMMUNOMODULATORY PEPTIDES | ORTHO PHARMACEUTICAL CORPORATION (US) | 1991-05-22 | — | — | EP | disclosed |
| US-4629723-A | IMMUNOREGULATING PEPTIDES | ORTHO PHARMACEUTICAL CORPORATION (US) | 1986-12-16 | — | — | US | disclosed |
| EP-0166612-A2 | Potent thymopentin analogs | ORTHO PHARMACEUTICAL CORPORATION (US) | 1986-01-02 | — | — | EP | disclosed |
| EP-0146266-A2 | Enzyme-resistant immunomodulatory peptides | ORTHO PHARMACEUTICAL CORPORATION (US) | 1985-06-26 | — | — | EP | disclosed |
| US-4505853-A | GLANDULAR DISORDERS | ORTHO PHARMACEUTICAL CORPORATION (US) | 1985-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220348558-A1 | INHIBITORS OF ENCEPHALITIC ALPHAVIRUSES | NEFM, EIF2AK2, PMP22 | CYP4F2 1356/4885CYP4A11 2023/4885ARG1 1712/4885 |
| US-20240065261-A1 | PENETRATING CRYOPROTECTION AGENTS AND METHODS OF MAKING AND USING SAME | SLC29A1, SLC29A2, SLC43A1 | CYP4F2 3771/4885CYP4A11 4070/4885ARG1 1011/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.